Cargando…
Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer
OBJECTIVE: The primary goal of this study was to determine the difference of abundance of CD4+, CD8+ and CD56+ bronchoalveolar fluid’s lymphocytes and their subpopulations between cancerous lung and healthy lung from the same patient. METHODS: Mini-bronchoalveolar lavage was taken from 55 patients f...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVICENA, d.o.o., Sarajevo
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570940/ https://www.ncbi.nlm.nih.gov/pubmed/23408789 http://dx.doi.org/10.5455/aim.2011.19.132-137 |
_version_ | 1782259127338139648 |
---|---|
author | Jusufovic, Edin Prnjavorac, Besim Iljazovic, Ermina Kosnik, Mitja Keser, Dragan Korosec, Peter Stahov, Jugoslav Zukic, Edin Sejdinovic, Rifat Ajanovic, Ekrem |
author_facet | Jusufovic, Edin Prnjavorac, Besim Iljazovic, Ermina Kosnik, Mitja Keser, Dragan Korosec, Peter Stahov, Jugoslav Zukic, Edin Sejdinovic, Rifat Ajanovic, Ekrem |
author_sort | Jusufovic, Edin |
collection | PubMed |
description | OBJECTIVE: The primary goal of this study was to determine the difference of abundance of CD4+, CD8+ and CD56+ bronchoalveolar fluid’s lymphocytes and their subpopulations between cancerous lung and healthy lung from the same patient. METHODS: Mini-bronchoalveolar lavage was taken from 55 patients from lung with cancer and healthy lung. After laboratory processing and addition of CD4, CD8, CD27, CD28 and CD56 antibody, the material was analyzed by flow cytometer. Results from lung with cancer were compared to the ones from the healthy lung. The examined patients were the test and the control group at the same time. RESULTS: CD27+28+ forms of CD4+ and CD8+ lymphocytes are more activated in the cancerous lung compared to healthy lung, while the CD27-28- forms are less activated in diseased lung. CD4+ forms of CD56+ lymphocytes are more activated in cancerous lung compared to the health lung, while the CD8+ forms are less activated in diseased lung. CONCLUSION: Immature helper and cytotoxic T lymphocyte response, as well as regulatory NK and NKT cell response are more activated in cancerous lung compared to the health lung of the same patient. |
format | Online Article Text |
id | pubmed-3570940 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | AVICENA, d.o.o., Sarajevo |
record_format | MEDLINE/PubMed |
spelling | pubmed-35709402013-02-13 Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer Jusufovic, Edin Prnjavorac, Besim Iljazovic, Ermina Kosnik, Mitja Keser, Dragan Korosec, Peter Stahov, Jugoslav Zukic, Edin Sejdinovic, Rifat Ajanovic, Ekrem Acta Inform Med Article OBJECTIVE: The primary goal of this study was to determine the difference of abundance of CD4+, CD8+ and CD56+ bronchoalveolar fluid’s lymphocytes and their subpopulations between cancerous lung and healthy lung from the same patient. METHODS: Mini-bronchoalveolar lavage was taken from 55 patients from lung with cancer and healthy lung. After laboratory processing and addition of CD4, CD8, CD27, CD28 and CD56 antibody, the material was analyzed by flow cytometer. Results from lung with cancer were compared to the ones from the healthy lung. The examined patients were the test and the control group at the same time. RESULTS: CD27+28+ forms of CD4+ and CD8+ lymphocytes are more activated in the cancerous lung compared to healthy lung, while the CD27-28- forms are less activated in diseased lung. CD4+ forms of CD56+ lymphocytes are more activated in cancerous lung compared to the health lung, while the CD8+ forms are less activated in diseased lung. CONCLUSION: Immature helper and cytotoxic T lymphocyte response, as well as regulatory NK and NKT cell response are more activated in cancerous lung compared to the health lung of the same patient. AVICENA, d.o.o., Sarajevo 2011-09 /pmc/articles/PMC3570940/ /pubmed/23408789 http://dx.doi.org/10.5455/aim.2011.19.132-137 Text en © 2011 AVICENA http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Jusufovic, Edin Prnjavorac, Besim Iljazovic, Ermina Kosnik, Mitja Keser, Dragan Korosec, Peter Stahov, Jugoslav Zukic, Edin Sejdinovic, Rifat Ajanovic, Ekrem Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer |
title | Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer |
title_full | Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer |
title_fullStr | Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer |
title_full_unstemmed | Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer |
title_short | Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer |
title_sort | local cd4+, cd8+ and cd56+ t-lymphocite reaction on primary lung cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570940/ https://www.ncbi.nlm.nih.gov/pubmed/23408789 http://dx.doi.org/10.5455/aim.2011.19.132-137 |
work_keys_str_mv | AT jusufovicedin localcd4cd8andcd56tlymphocitereactiononprimarylungcancer AT prnjavoracbesim localcd4cd8andcd56tlymphocitereactiononprimarylungcancer AT iljazovicermina localcd4cd8andcd56tlymphocitereactiononprimarylungcancer AT kosnikmitja localcd4cd8andcd56tlymphocitereactiononprimarylungcancer AT keserdragan localcd4cd8andcd56tlymphocitereactiononprimarylungcancer AT korosecpeter localcd4cd8andcd56tlymphocitereactiononprimarylungcancer AT stahovjugoslav localcd4cd8andcd56tlymphocitereactiononprimarylungcancer AT zukicedin localcd4cd8andcd56tlymphocitereactiononprimarylungcancer AT sejdinovicrifat localcd4cd8andcd56tlymphocitereactiononprimarylungcancer AT ajanovicekrem localcd4cd8andcd56tlymphocitereactiononprimarylungcancer |